Skip to content

Dr K. VAN VAERENBERGH

Active Private limited companyfounded 2008active for 18 yearsAchterstraat 54, 9310 AalstKBO/BCE: BE 0898.208.518

Lifetime

18 annual accounts with figures on one time axis
peak of €480,891 in 2021
€466,377▲ 4.5%
peak of €468,772 in 2021
€364,795▲ 18.8%
peak of €1.9m in 2025
€1.9m▲ 1.8%
€124,145▲ 25.2%
Board1 name since 2008
1 director
Documentsfilings and deeds
31-08-202631 days late
2025micro format
Dividend €330,426Debts from €99,166 to €124,145Cash from €212,636 to €294,410

Key points

from the 2025 annual accounts

Equity

€1.9m ▲ 1.8%
1.92024+0.4Profit-0.3Dividend1.92025

Dr K. VAN VAERENBERGH paid out €330,426 in dividends. That is 91% of the 2025 profit.

Filings

18 annual accounts since 2008
AprilJune31 JulyOctober2010201520202025

Ten of the last ten came late. The 2019 accounts came in latest, 83 days after the end of the period.

Position in the sector

€364,795

Higher net result than 95% of companies in human health. The sector median is €59,541, over 21,360 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 17,817 companies had the same profile as Dr K. VAN VAERENBERGH has now. Each dot stands for 45 companies, two years later.

96.5%
were still trading
3.2%
stopped another way
0.3%
went bankrupt
  • Small
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 17,817 companies, not a prediction for Dr K. VAN VAERENBERGH. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0898208518
appointed as director Legal-form conversion: from private limited company (pre-2019) to private limited company · General meeting of 03-11-2023 · Gazette deed
Capital decrease of €123,300 to €18,600 The capital fell from €141,900 to €18,600 · Gazette deed
Capital increase of €123,300 to €141,900 The capital rose from €18,600 to €141,900 · General meeting of 19-12-2013 · Gazette deed
All 34 events

Comparable companies

same main activity, similar in size and age
Company
Dr K. VAN VAERENBERGH Aalst €2.1m €466,377 93.9% -
DOKTER NIKOLAAS DE NEVE, ANESTHESIST Laarne €1.9m €458,481 96.4% -
Dokter Christel Mestach Merelbeke-Melle €1.9m €472,944 87.5% -
Dr. BART VAN LIERDE, pediater Maarkedal €2.0m €503,507 75.5% -
Dokter Van Hecke Lien, dermatologe Oudenaarde €2.0m €457,217 72.7% -
Dr. C. De Meyere Schilde €2.0m €465,954 91.7% 0
DR. JORIS DE BONDT,CARDIOLOGIE Nijlen €2.0m €494,434 73.1% 0

These companies have the same main activity as Dr K. VAN VAERENBERGH: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €1.9m and €2m, founded between 2006 and 2010.

Official details

Source: KBO
Status
Active since 29-05-2008Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.186.927.1589300 Aalst, since 19-05-2008
Financial year end
31 December
Peppol
Reachable since 31-12-2025
Company details

Annual accounts 2025

≈ €700,000estimated
€2.1m▲ 3.0%
Filing
Filed on 31-08-2026
Financials

Insights on Dr K. VAN VAERENBERGH

Dr K. VAN VAERENBERGH files the micro format. That format states no turnover. The gross margin rose from €270,948 in 2008 to €466,377 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr K. VAN VAERENBERGH

What is the company number of Dr K. VAN VAERENBERGH?
The company number of Dr K. VAN VAERENBERGH is 0898.208.518. The VAT number is the same number with BE in front: BE 0898.208.518.
Where is Dr K. VAN VAERENBERGH based?
The registered office is at Achterstraat 54, 9310 Aalst.Company details
What does Dr K. VAN VAERENBERGH do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr K. VAN VAERENBERGH?
Dr K. VAN VAERENBERGH is a private limited company (BV).
When was Dr K. VAN VAERENBERGH founded?
Dr K. VAN VAERENBERGH was founded on 29-05-2008.
Is Dr K. VAN VAERENBERGH still active?
Yes, Dr K. VAN VAERENBERGH is an active enterprise in the KBO register.
What is the turnover of Dr K. VAN VAERENBERGH?
The turnover in financial year 2025 is about €700,000. This figure is estimated from the gross margin of €466,377 and 31 comparable companies (NACE 86220). It probably lies between €620,000 and €980,000.Financials
Is Dr K. VAN VAERENBERGH profitable?
In financial year 2025, Dr K. VAN VAERENBERGH made a profit of €364,795.
Where can I find the annual accounts of Dr K. VAN VAERENBERGH?
Dr K. VAN VAERENBERGH filed 18 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr K. VAN VAERENBERGH due?
Dr K. VAN VAERENBERGH must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.